To confirm these findings in human disease, we evaluated PRKCB in a publicly available breast cancer dataset [Karnoub et al. (43)] comparing stroma isolated from invasive ductal breast carcinoma compared to normal breast tissue. This evidence concerns the gene PRKCB and invasive ductal breast carcinoma.